Keyphrases
Active Agent
25%
Advanced Search
25%
Antibody Titer
25%
Clinical Trials
100%
Disease Severity
25%
Drug Efficacy
50%
Drug Safety
25%
Federal Funding
25%
Funding Sources
25%
Government Agencies
25%
Inclusion Criteria
25%
Industry-funded
25%
Inflammatory Markers
25%
Multicenter Trial
25%
Ongoing Clinical Trials
50%
Ongoing Trials
100%
Open Study
25%
Pharmaceutical Industry
25%
Placebo-controlled
25%
Primary Sponsors
25%
Remission Rate
25%
Remission Times
25%
Search Options
25%
Status Report
100%
Systemic Lupus Erythematosus
100%
Systemic Lupus Erythematous
100%
Time to Remission
25%
University-industry
25%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Disease
20%
Disease Severity
20%
Drug Safety
20%
Placebo
20%
Remission
40%
Systemic Lupus Erythematosus
100%